CDK inhibitors
New Strategy Proposed for HR+, HER2– Advanced Breast Cancer
In certain patients with HR+, HER2– advanced breast cancer, switching from an aromatase inhibitor to ...
AUGUST 26, 2025
FDA Warns About Lung Inflammation Caused by CDK 4/6 Inhibitors
The FDA issued a safety announcement warning that the entire class of cyclin-dependent kinase 4/6 nhibitors used to ...
SEPTEMBER 16, 2019
Load more